Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

SCS Closures in Ontario Spark Harm Reduction Concerns

Ontario will replace nine supervised consumption sites with HART hubs, but critics warn the lack of harm reduction could increase overdoses and strain emergency services.

Two EMA Moves Broaden Options in Hemophilia, Iron Deficiency

The European Medicines Agency has backed Feraccru for adolescent iron deficiency and expanded Hympavzi prophylaxis to hemophilia patients with or without inhibitors.

EU Panel Expands Options in Relapsed Childhood Leukemia

The proposed EU expansion would extend access to Besponsa, a CD22-directed therapy in children with relapse of acute lymphoblastic leukemia or in whom prior treatment has failed.

Zoster Vaccine Uptake Low in Rheumatic Disease in the US

Recombinant zoster vaccine uptake in adults with rheumatic disease reached around 10% in the 20 months following the updated 2021 recommendations, with lack of tracking and education seen as barriers.

Emerging Norovirus Vaccines Face Scientific, Policy Hurdles

Researchers are advancing several norovirus vaccine candidates, such as oral tablet-based platforms, mRNA vaccines, and virus-like particle technologies.

Fibromyalgia Reframed and Linked to Altered Pain Processing

The condition is best understood as a symptom-based disorder of altered pain processing with partial overlap with post-viral syndrome, but important distinctions remain.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Latest News

Ontario will replace nine supervised consumption sites with HART hubs, but critics warn the lack of harm reduction could increase overdoses and strain emergency services.

The European Medicines Agency has backed Feraccru for adolescent iron deficiency and expanded Hympavzi prophylaxis to hemophilia patients with or without inhibitors.

The proposed EU expansion would extend access to Besponsa, a CD22-directed therapy in children with relapse of acute lymphoblastic leukemia or in whom prior treatment has failed.

Recombinant zoster vaccine uptake in adults with rheumatic disease reached around 10% in the 20 months following the updated 2021 recommendations, with lack of tracking and education seen as barriers.

Researchers are advancing several norovirus vaccine candidates, such as oral tablet-based platforms, mRNA vaccines, and virus-like particle technologies.

The condition is best understood as a symptom-based disorder of altered pain processing with partial overlap with post-viral syndrome, but important distinctions remain.

News All Time

EU Backs New Oral Option in Psoriatic Arthritis

The European Medicines Agency has endorsed expanded use of Sotyktu for psoriatic arthritis, recommending approval after clinical trials showed improvement in joint symptoms.

What We Thought We Knew About the Thymus May Be Wrong

The seemingly unassuming organ has become an emerging target for healthspan, longevity, and precision oncology.

Anifrolumab Shows Promise in Real-World Lupus Care

Anifrolumab treatment is linked to improved disease activity and reduced steroid use and has an acceptable safety profile in routine care of patients with systemic lupus erythematosus.

The Death of the Medical Fax Is Foretold — Again

Medical offices are sick and tired of faxing, and federal officials agree. But modernization won’t be easy.

Rare Immune Disorder Drug Wins EU Panel Support

EMA’s panel backs a targeted therapy, which reduces lymphadenopathy and restores B-cell populations in patients with activated phosphoinositide 3-kinase delta syndrome.

Food-Allergic Adults May Shun Nonallergenic Items

Because of fear of allergic reactions, some patients need psychological counseling and dietary support for a more positive attitude toward food.

Roflumilast Promising for AD in Children Down to Age 3 Mos

Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study.

Upadacitinib Significantly Improves Vitiligo vs Placebo

The JAK1 inhibitor in development for treating nonsegmental vitiligo was superior to placebo on investigator ratings in two phase 3 trials.

Adrenal Crisis: Rare, Deadly, Preventable — Here’s How

Adrenal crisis remains rare but life-threatening. Better patient, family, and clinician education could help prevent deaths.

Psychosocial Factors May Improve ED Suicide Risk Prediction

Augmentation of data-based risk models with psychosocial factors obtained from clinical notes may improve the prediction of suicide attempts in patients with suicidal ideation, a study shows.

Mar 27 2026 This Week in Cardiology

Early aortic valve replacement in aortic stenosis, left atrial appendage occlusion in JAMA Cardiology, and a big preview of the upcoming American College of Cardiology meeting are the topics John Mandrola, MD, discusses in this week’s podcast.

South Carolina Could Declare Measles Outbreak Over by April 26, Health Official Says

South Carolina could declare its ongoing measles ⁠outbreak over by April 26 if no additional infections are reported, the state's ⁠top epidemiologist said during a briefing...

Allergic Rhinitis May Worsen Asthma Risk in CRS

Individuals with chronic rhinosinusitis face an elevated risk of developing new-onset asthma and subsequent exacerbations, and concurrent allergic rhinitis increases the risk.

EU Chemicals Agency Backs Ban on PFAS 'Forever Chemicals'

The European Chemicals Agency on Thursday recommended a broad EU-wide ban on PFAS, or "forever chemicals," with some ⁠exemptions.

A Ubiquitous Alcohol Emerges as Allergen of 2026

Benzyl alcohol, though generally safe, can be a stealth cause of allergic dermatitis through a variety of exposures.

Survey Examines Current Practice in Skin of Color Clinics

Clinics dedicated to treating patients with skin of color are increasingly common, but a survey suggests they are addressing this need with limited or no institutional support.

Recommended News For You

The diamonds that could find cancer

Two medications might work better for breast cancers that are resistant to one.

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Investigations may result in novel combination therapies for early-stage lung cancers.

Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation

Surgeons are at higher risk of cancer, study suggests

Recommended Articles For You

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide 

Subchorionic Hematoma: Causes, Symptoms, and Treatment  

Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology 

IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High levels of traumatic stress found in caregivers of adult cancer patients

2.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

3.

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

4.

DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance

5.

In a recent study, Kencur ginger's anti-cancer properties were discovered.

1.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

2.

Understanding Dasatinib: A Promising Drug for Cancer Treatment 

3.

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances

4.

Case Study: The Role of Machine Learning in the Detection of Skin Cancer

5.

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

3.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot